- Takeda is considering a new bid for Adderall drugmaker Shire, raising the share price to 47 British pounds (about $66) per share up from 46.50 per share (about $65), Bloomberg reported Friday.
- Shire has already
- Interest in Shire almost turned into a bidding war between Takeda and Allergan
ADVERTISEMENT
Takeda's considering turning up the heat on its bid for Shire (TKPYY, SHPG)
Shire has already turned down three offers already from the Japanese pharmaceutical company Takeda, including one worth $60 billion.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
ADVERTISEMENT